Teva Launches Generic Ritalin LA

Teva announced the launch of Methylphenidate HCl Extended-Release Capsules LA, the generic version of Novartis' Ritalin LA Capsules.

Ritalin LA, a CII stimulant, is indicated for attention deficit hyperactivity disorder (ADHD). The exact mechanism of action of CNS stimulants in the treatment of ADHD is unknown. However, it is believed that these agents block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space.

Methylphenidate HCl Extended-Release Capsules LA are available from Teva in 20mg, 30mg, and 40mg dosage strength capsules in 100-count bottles.

For more information call (888) TEVA-USA or visit www.tevausa.com.